Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine.
作者信息
Xie Fang, Huang Mei, Lin Xiansheng, Liu Chenhai, Liu Zhen, Meng Futao, Wang Chao, Huang Qiang
机构信息
Department of General Surgery, Anhui Provincial Hospital, No. 17, Lujiang Road, Hefei, Anhui Province, China.
Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, Hefei, China.
出版信息
Sci Rep. 2023 Nov 28;13(1):20934. doi: 10.1038/s41598-023-48298-9.
Abstract
摘要
相似文献
1
Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine.
Sci Rep. 2023 Nov 28;13(1):20934. doi: 10.1038/s41598-023-48298-9.
2
The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine.
Sci Rep. 2018 May 25;8(1):8102. doi: 10.1038/s41598-018-26496-0.
3
The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer.
Cancers (Basel). 2021 Jul 11;13(14):3470. doi: 10.3390/cancers13143470.
4
Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinoma.
Int J Cancer. 2020 Nov 15;147(10):2847-2861. doi: 10.1002/ijc.33137. Epub 2020 Jun 29.
5
Rubicon can predict prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant chemoradiotherapy.
Int J Clin Oncol. 2023 Apr;28(4):576-586. doi: 10.1007/s10147-023-02306-0. Epub 2023 Feb 24.
6
CIP2A down regulation enhances the sensitivity of pancreatic cancer cells to gemcitabine.
Oncotarget. 2016 Mar 22;7(12):14831-40. doi: 10.18632/oncotarget.7447.
7
ATG4B Inhibitor UAMC-2526 Potentiates the Chemotherapeutic Effect of Gemcitabine in a Panc02 Mouse Model of Pancreatic Ductal Adenocarcinoma.
Front Oncol. 2021 Nov 18;11:750259. doi: 10.3389/fonc.2021.750259. eCollection 2021.
8
Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Oncotarget. 2016 Sep 20;7(38):61469-61484. doi: 10.18632/oncotarget.11129.
9
Gemcitabine enhances OSI-027 cytotoxicity by upregulation of miR-663a in pancreatic ductal adenocarcinoma cells.
Am J Transl Res. 2019 Jan 15;11(1):473-485. eCollection 2019.
10
Novel Seleno-Aspirinyl Compound AS-10 Induces Apoptosis, G1 Arrest of Pancreatic Ductal Adenocarcinoma Cells, Inhibits Their NF-κB Signaling, and Synergizes with Gemcitabine Cytotoxicity.
Int J Mol Sci. 2021 May 7;22(9):4966. doi: 10.3390/ijms22094966.
本文引用的文献
1
SETDB1 promotes glioblastoma growth via CSF-1-dependent macrophage recruitment by activating the AKT/mTOR signaling pathway.
J Exp Clin Cancer Res. 2020 Oct 15;39(1):218. doi: 10.1186/s13046-020-01730-8.
2
CtBP1 promotes tumour-associated macrophage infiltration and progression in non-small-cell lung cancer.
J Cell Mol Med. 2020 Oct;24(19):11445-11456. doi: 10.1111/jcmm.15751. Epub 2020 Sep 10.
3
Increased Six1 expression in macrophages promotes hepatocellular carcinoma growth and invasion by regulating MMP-9.
J Cell Mol Med. 2019 Jul;23(7):4523-4533. doi: 10.1111/jcmm.14342. Epub 2019 May 2.
4
Antiproliferative and Apoptosis Triggering Potential of Paclitaxel-Based Targeted-Lipid Nanoparticles with Enhanced Cellular Internalization by Transferrin Receptors-a Study in Leukemia Cells.
Nanoscale Res Lett. 2018 Sep 6;13(1):271. doi: 10.1186/s11671-018-2688-x.
5
Actein induces autophagy and apoptosis in human bladder cancer by potentiating ROS/JNK and inhibiting AKT pathways.
Oncotarget. 2017 Nov 1;8(68):112498-112515. doi: 10.18632/oncotarget.22274. eCollection 2017 Dec 22.
6
Cytotoxic Compounds from Juglans sinensis Dode Display Anti-Proliferative Activity by Inducing Apoptosis in Human Cancer Cells.
Molecules. 2016 Jan 21;21(1):E120. doi: 10.3390/molecules21010120.
7
Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
PLoS One. 2015 Jul 17;10(7):e0132977. doi: 10.1371/journal.pone.0132977. eCollection 2015.
Zotero 插件